Gilead Sciences
GILD
1,564 hedge funds and large institutions have $77.5B invested in Gilead Sciences in 2018 Q1 according to their latest regulatory filings, with 122 funds opening new positions, 578 increasing their positions, 693 reducing their positions, and 116 closing their positions.
15% more funds holding in top 10
Funds holding in top 10: 52 → 60 (+8)
6% more capital invested
Capital invested by funds: $73.2B → $77.5B (+$4.34B)
5% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 116
0.71% more ownership
Funds ownership: 78.25% → 78.96% (+0.71%)
1% less funds holding
Funds holding: 1,575 → 1,564 (-11)
7% less call options, than puts
Call options by funds: $1.62B | Put options by funds: $1.74B
17% less repeat investments, than reductions
Existing positions increased: 578 | Existing positions reduced: 693
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$844M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$282M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$225M |
| 4 |
JP Morgan Chase
New York
|
+$214M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$148M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$289M |
| 2 |
Morgan Stanley
New York
|
-$271M |
| 3 |
Bank of New York Mellon
New York
|
-$225M |
| 4 |
State Street
Boston,
Massachusetts
|
-$204M |
| 5 |
Renaissance Technologies
New York
|
-$201M |
GILD Hedge Fund Activity: Q1 2018 in Review
1,564 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2018, worth a combined $77.5B — up 5.9% from $73.2B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new GILD positions and 116 closed out — a net gain of 6 holders — while 578 added to existing stakes and 693 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $844M. The largest seller was Skandinaviska Enskilda Banken (SEB), cutting an estimated $289M.
- 1,564 institutional investors held Gilead Sciences (GILD) as of Q1 2018, down from 1,575 in Q4 2017.
- Funds reported $77.5B of Gilead Sciences stock for Q1 2018, up 5.9% quarter-over-quarter.
- 122 funds opened new Gilead Sciences positions in Q1 2018 and 116 closed out, a net change of +6 holders.
- The largest Gilead Sciences buyer in Q1 2018 was Capital Research Global Investors, an estimated $844M added.
- The largest Gilead Sciences seller in Q1 2018 was Skandinaviska Enskilda Banken (SEB), an estimated $289M sold.
Based on aggregated 13F filings for Q1 2018.